Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Debt holders of Anergis are asked to get in touch:
https://shab.ch/#!/search/publications/detail/ca34aad6-0517-44db-8572-c255f9faa903
https://shab.ch/#!/search/publications/detail/01d9a471-ff03-4b15-9605-576cd53ce84c
I would like to see their balance sheet to check intangible assets.
Unfortunately I am not familiar with Swiss regulations. Anergis is publishing the first and second call on two consecutive days. That could possibly mean that they have no debt holders left and that could mean they received "some" money, perhaps from a sale of intangible assets. - I am just guessing.
Thanks, the same to you.
I don't like shares to fall while I own them and I don't like chart analysis to predict share price in special with such small companies and volatile shares. But look at the chart: 0.08 is not a surprise. That looks just normal, nothing exciting. Nevertheless you are right that share price could go down further if there are no news since no news means no progress.
In my eyes there's nothing to be worried about today. Just one single trader being impatient can sell and bring price down. (I just checked the volume; the drop was because of 1500 shares - sometimes I find that quantity if I sweep up my office floor.)
Other things are more important in my opinion. In the Biopole story Mr. Kempers wrote: "[...] and three more are ongoing, including one at Bern University Hospital and another with Prof. T. Geiser and Dr. Amiq Gazdar at DBMR [...]". Why didn't he mention the third one? And why did he put time in that interview? He is a CEO and surely works conscientiously, and there's no audience he could direct that to - no customers and barely public interest. So, why spend that time?
I am just always looking for a reason.
No news as far as I can see.
Thanks for that link. Very interesting!
Also thanks to Mr. Kempers for that.
Thanks! I will send an email.
Some years ago I sent an email to dwalker@enableipc.com and got a detailed reply. But now the domain is used by a German SEO blog.
$36800 on bid, apparently without news.
Has anyone an email address to contact the company?
Thanks. I think life is currently everywhere just the same: Covid-19 all day long. It gets boring and annoying.
And on 13th of November (two weeks after Anergis' meeting) Mr. Kempers wrote: "[...] Anergis and Mymetics are currently in negotiation about a possible business relationship, but there is no assurance that this will be concluded."
Great! Looking forward to that.
I have been checking this every day now.
Just found, as of today: Anergis is on liquidation!
https://shab.ch/#!/search/publications/detail/872a72bd-af40-426d-9868-5b961638f8b9
They decided that on 29th of October! And no one tells us about that.
I am a bit angry now.
And what does that mean in regard of birch pollen... If the company is liquidated the birch pollen project would be an asset. Therefore they probably have sold the product.
Good, thanks. We really should get something from Mr. Kempers very soon. "Covid-19" is overdue and "birch pollen" apperntly were disposed in a publication.
Just in the news: Merck & Co failed in developing two Covid-19 vaccines.
Are we affected?
@Estrella: I only have a free account with no special functionality.
I am impressed: 0.0037, but I couldn't find anything new.
Mr. Kempers, you are the only one I can ask at biopole: Would you please go over to the office of Anergis, look through a window and tell us about what's going on there? Or perhaps did someone mention something in passing at the hot dog stand?
(Let's see, if my try works. )
I don't know, but that's surely market maker's action, not traders'. Perhaps there is a problem in their algorithms or something lies in front of us that makes them act.
Bid and Ask seem to be a bit crazy. Orders coming in and going out continuously.
I hope so. Waiting for this for almost 9 months.
Is finally something going on with EIPC, Mr. Walker?
Nothing for years and years.
Solrayo website ist gone, too.
There are also news regarding Anergis and Stallergenes at Mymetics' website: "Publication in "Clinical & Experimental Allergy""
https://www.mymetics.com/media-center/publication-national-center-biotechnology-information/
Anergis.ch is down the whole day. Perhaps because of an update?
Maria Elena Bottazzi at Twitter: "Much has happened since April and we are now at the brink of realizing our #COVID19 Global Health Vaccine in partnership with @biological_e"
I am curious about the influence on Mymetics.
Maria Elena Bottazzi at Twitter: "All I want for Christmas is a Vaccine".
I would like that as well!
I hope, there's no negative subtone in that message. It's not Santa's job to develop a vaccine.
Merry Christmas to all!
May your hard work be rewarded.
Thanks!
Then I would gladly wait for the 24th to get a nicely packaged buyout.
Shouldn't we have gotten news this month?
Only eight business days left.
Recently three companies/collaborations published good resp. very good results for their SARS-CoV-2 vaccines. One could think, and I actually did for a short period of time, that this is not good news for us. But now I think it is good news.
If all these fast working big companies would fail we probably would fail as well. But it's not important for Mymetics to become the only supplier of a SARS-CoV-2 vaccine, whereby that would be nice. The good news is developing a working vaccine is not too hard but we could make it easy to supply the whole world with it.
I still don't understand why volume and share price increased after and in anticipation of the news from 18th of Nov.. I am wondering if that is better than the collaboration with the Helmholtz Center of Infection Research.
Perhaps recent action is not in response to these news but there's more to come. I am waiting full of hope.
Is there any evidence for a buyout?
The same as three months ago:
You (and others) are doing a great job here. Thanks a lot for that!
Unfortunately I don't understand many things like all the technical aspects and many conclusions resulting from them. Mainly I have to stick to what Mr. Kempers publishes.
The collaboration with HZI is nice, but I
- expected "Additional preclinical studies at other sites will be announced in the coming weeks." and
- hoped for a partnering with a commercial company. Science is great but working with research institutes doesn't bring us closer to revenue and profits.
Therefore I should not be surprised about the lack of interest in Mymetics' stocks. And I can well understand some people want to get out of their investment in this company. I am waiting and hoping for almost 6 years now. Mr. Kempers, wouldn't you like to retire at $3/share with your 21.1 million shares... maybe it helps: take some spinach or an energy drink from the fridge. You can do it; people like me can only feverishly look forward and wipe cold sweat from the forehead while every tick down eats up old-age provision.
News out at otcmarkets.com and yahoo, but not yet at company website.
I don't know. In spring I thought 0.14 would be a fair price in that announced reverse merger. But at that time the reverse merger seemed to be secured.
New 8-K: Old Directors are retiring.
And Ekimas has an email address now as well as a new office address.
But there's still no 10-K and 10-Q available.
Every week I am folding out one more finger of my right hand and the calendar tells me tomoorow is my ring finger's big day. He is numbered with a 4.
What may "coming" mean in numbers?
otcmarkets.com shows volume. At IB there's no bid and ask and no volume. I would buy some shares.
Reverse Split will be done today - got a message from my broker; even on ihub ticker symbol change is already done.
Somehow true.
I am curious about these "other sites".